Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Real-World Data

Responses to Zito and Doshi

Basu, Anirban, PhD; Axelsen, Kirsten, MS; Grabowski, David C., PhD; Meltzer, David O., MD, PhD; Polsky, Daniel, PhD; Ridley, David B., PhD; Wiederkehr, Daniel, MPh; Philipson, Tomas J., PhD

doi: 10.1097/MLR.0000000000000655
Point-Counterpoint
Buy

*Pharmaceutical Outcome Research and Policy Program, Department of Pharmacy, University of Washington, Seattle, WA

Pfizer Inc., New York, NY

Department of Health Care Policy, Harvard Medical School, Boston, MA

§Departments of Medicine and Economics, The School of Public Policy Studies, University of Chicago, Chicago, IL

Departments of Medicine and Health Care Management at Wharton School, University of Pennsylvania, Philadelphia, PA

The Fuqua School of Business, Duke University, Durham, NC

#Harris School of Public Policy Studies, University of Chicago, Chicago, IL

A.B., D.C.G., D.O.M., D.P., D.B.R., and T.J.P. were paid by Pfizer for their travel for meeting and time. Two of the coauthors, K.A. and D.W., are employed by Pfizer Inc.

Reprints: Anirban Basu, PhD, Pharmaceutical Outcome Research and Policy Program, Department of Pharmacy, University of Washington, 1951 NE Pacific Street, P.O. Box 357630, Seattle, WA 98195-7630. E-mail: basua@uw.edu.

Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.